Delivery Order SPE2DB24D8002-SPE2DB24FJMVN

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $5,560.45 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,138.04 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a prescription medication. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the agency's ECAT Generation V Program. This single-award IDC allows the company to provide a...
This federal contract award, valued at $12,770.24, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the medication Eliquis 5 mg tablets. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This single-award IDC allows the company to provide...
This federal contract, awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., is a $2,864.79 firm fixed-price delivery order for the supply of Eliquis 5 mg tablets. The award, which does not have a set-aside designation, is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc., a self-certified small disadvantaged business, to provide a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $8,304.36, is for the delivery of Eliquis 5 mg tablets. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $21,299.49 firm fixed-price delivery order is for the pharmaceutical product Eliquis 5 mg tablet, 60-count bottles. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a wide range of...
This federal contract award, valued at $5,011.95, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Eliquis 5 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The award, with a ceiling value of $4,188.11, is a firm fixed-price delivery order contract with a completion date of February 9, 2024. Dakota Drug, Inc. is a key strategic supplier for the DLA's medical supply chain needs, holding a significant single-award Indefinite Delivery...
This federal contract award, identified as SPE2DB24D8001|SPE2DB24FKZAJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Dakota Drug, Inc. The $13,689.51 fixed-price delivery order is for the supply of Eliquis 5 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. is a self-certified small disadvantaged business that operates as a for-profit subchapter S corporation. The company specializes in providing pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $13,109.49 and a period of performance through August 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, which has a total potential value of $999,999,999.00 and is used to procure...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB24FJMVN
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,221.90 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a prescription anticoagulant medication.

The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and simulation equipment for the U.S. Armed Forces. This single-award IDC, identified as SPE2DB24D8001, allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support military medical operations through December 31, 2025.

Generated 11/27/24, 9:36 AM